Oscar Izeboud

Oscar Izeboud is the Chief Executive Officer of Scenic Biotech and has served in this role since July 2020. In addition to leading Scenic Biotech, Oscar is an independent member of the Board of Directors at TME Pharma and Nomad Bioscience GmbH. Oscar is also a co-owner of Kaapse Brouwers and has held a previous position as a Board member of Luciole Medical AG, which recently acquired Spiegelberg GmbH. Prior experience includes managing director roles at NIBC Bank and Kempen & Co, specializing in corporate finance and capital markets for innovative and technology companies, particularly in the life sciences and healthcare sectors. Oscar's earlier roles include director positions at Crucell (Johnson & Johnson) and TNO, along with a sales position at Specs - Compound Handling BV. Academic qualifications include an M.Sc. in Biopharmaceutical Sciences/Chemistry from Leiden University and a Ph.D. in Pharmacology from Utrecht University.